N Novonesis (Novozymes) B
N
Open
367.7 0.14
Übersicht
Veränderung der Aktienkurses
24h
Min
365.9
Max
369.8
Einkommen | 76M 199M |
|---|---|
Verkäufe | 123M 1.1B |
KGV Branchendurchschnitt | 39.155 37.623 |
EPS | 4.258 |
Dividendenrendite | 0.23 |
Gewinnspanne | 17.788 |
Angestellte | 10,933 |
EBITDA | 151M 268M |
Dividendenrendite Branchendurchschnitt | 0.23% 2.53% |
|---|
Marktkapitalisierung | -11B 175B |
|---|---|
Vorheriger Eröffnungskurs | 367.56 |
Vorheriger Schlusskurs | 367.7 |
Novonesis (Novozymes) B Chart
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
Ähnliche Nachrichten
Novonesis (Novozymes) B Prognose
Finanzen
Vertriebs- und Verwaltungskosten
Betriebsaufwand
Gewinn vor Steuern
Verkäufe
Umsatzkosten
Bruttogewinn aus dem Verkauf
Zinsaufwand für Schulden
EBITDA
Betriebsergebnis
$
Über Novonesis (Novozymes) B
Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.
